No abstract available
Keywords:
MOGAD; current; editorial; knowledge; trends.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic MOGAD, current knowledge and future trends
References
-
-
Dubey D, Pittock SJ, Krecke KN. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. (2019) 76:301–9. 10.1001/jamaneurol.2018.4053
-
DOI
-
PMC
-
PubMed
-
-
Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, et al. . Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. (2022) 13:885218. 10.3389/fneur.2022.885218
-
DOI
-
PMC
-
PubMed
-
-
Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. . Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria. Lancet Neurol. (2023). 10.1016/S1474-4422(22)00431-8
-
DOI
-
PubMed
-
-
Marignier R, Hacohen Y, Cobo-Calvo A. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. (2021) 20:762–72. 10.1016/S1474-4422(21)00218-0
-
DOI
-
PubMed